Tag: Coronavirus information (COVID-19)
News
Britain partners with Oxford firm to assess coronavirus vaccine T cell responses
Britain has signed supply deals for six different coronavirus vaccine candidates, including those being made by AstraZeneca and Pfizer and BioNTech, seen as among...
Drug Research
RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate
RedHill Biopharma, a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib, currently...
News
Xerox Highlights COVID-19, Diversity and Climate Change Efforts in 2020 Corporate Social Responsibility Report
Xerox Holdings Corporation has published its 2020 Global Corporate Social Responsibility Report detailing data, accomplishments and goals relating to its work regarding the environment,...
News
Moderna CEO Says COVID-19 Vaccine Could Get Emergency Approval in December
As the top three COVID-19 vaccine projects get closer to the finish line, everybody is paying attention to when they might be available. Moderna...
News
Brazil COVID-19 vaccine trial continues despite volunteer death
Clinical trials of the Covid-19 vaccine being developed by Oxford University and AstraZeneca PLC will continue in Brazil despite the death a volunteer, Brazilian...
Drug Research
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its...
News
Dyadic C1 protein expression platform explored in fight against COVID-19
Dyadic International, Inc. a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















